Retail giant Walmart halts sales of Zantac and related drugs

Zantac may contain a potentially dangerous contaminant.

Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug.

The nation's largest retailer said Wednesday that it suspended sales of all drugs sold over the counter, or without a prescription, that include Zantac's active ingredient, ranitidine.

The Hy-Vee supermarket and pharmacy chain made a similar move earlier this week. The West Des Moines-based retailer operates more than 240 stores in Nebraska and other states.

The U.S. Food and Drug Administration said last month it detected low levels of a probable cancer-causing chemical in Zantac and related generic drugs to treat ulcers and reflux disease. The same chemical has been linked to dozens of recalls of prescription blood pressure drugs in the past year.

The drugstore chains CVS Health, Walgreens and Rite Aid have already pulled Zantac products from their shelves.

Get the latest health headlines and inspiring stories straight to your inbox.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Commenting is limited to Omaha World-Herald subscribers. To sign up, click here.

If you're already a subscriber and need to activate your access or log in, click here.

Load comments

You must be a full digital subscriber to read this article You must be a digital subscriber to view this article.